LICHTLEITERKÖRPER

European patent · EP4162919 · In force

Register entry

Publication number
EP4162919
Application number
EP21817420
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 4, 2021
Published
Apr 12, 2023
Granted
Dec 10, 2025
Protection ends at the latest
Jun 3, 2041
Next annual fee due
Jun 30, 2026
IPC classes
A61J 15/00 (2006.01)
Priority
JP 2020097941 04.06.2020
PCT application
PCT/JP2021/021378 04.06.2021
PCT publication
WO2021/246520 09.12.2021
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 21, 2026

    Change

    Published in Swissreg on 21.10.2026

  2. Dec 10, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 10.12.2025

Parties

Holder

Otsuka Clinical Solutions, Inc.

5194-63, Katsurenhaebaru, Uruma, Okinawa 904-2311, JP

Pax Co., Ltd.

3-1-5205, Kachidoki 6-chome Chuo-ku, Tokyo 104-0054, JP

Otsuka Pharmaceutical Factory, Inc.

115 Aza-Kuguhara Tateiwa Muya-cho Naruto-shi, Tokushima 772-8601, JP

Inventor

MIIKE, Shinya

Tokyo 113-0033, JP

ENDOH, Hiroshi

Tokyo 113-0033, JP

FURUYAMA, Takeshi

Tokyo 113-0033, JP

SUZUKI, Yutaka

Tokyo 104-0054, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.